Maximizing Revenue with Transactional Patent Strategies

A patent is only as valuable as the strategy behind it. While many companies obtain patents purely to protect their inventions from competitors, the more commercially sophisticated approach is to treat patents as revenue-generating assets – ones that can be licensed, traded, and leveraged in business transactions. This is the essence of a transactional patent strategy: using your intellectual property not just as a shield, but as a source of income, market access, and strategic partnerships. For Indian companies navigating an increasingly competitive global landscape, understanding this approach is no longer optional – it’s essential.

What is a transactional patent strategy? 🔗

A transactional patent strategy focuses on deriving commercial value from patents through business transactions, rather than simply using them to block competitors. Patent licensing is central to this approach – it allows a patent holder (the licensor) to grant another party (the licensee) the right to use, manufacture, or sell a patented invention in exchange for royalty payments or licensing fees. The patent owner retains legal ownership while earning from the technology’s commercial use. This strategy is especially relevant for companies that have developed valuable technology but may lack the manufacturing capacity, distribution networks, or capital to commercialize it independently.

Rather than viewing patents solely as legal tools to prevent copying, transactional strategies recognize patents as tradable business assets that can generate recurring revenue, open new markets, and build collaborative relationships across industries.

Out-licensing: monetizing your technology without manufacturing it 🔗

Out-licensing is one of the most straightforward and widely used transactional patent strategies. Here, the patent owner grants external parties the right to use its patented technology in exchange for royalty payments. This creates a reliable income stream without requiring the licensor to invest in production, marketing, or distribution.

Types of out-licensing arrangements 🔗

Out-licensing is not one-size-fits-all. The structure of the agreement depends on the commercial goals of both parties. The three most common forms are:

Exclusive licensing grants a single licensee the sole right to use the technology within a defined territory, industry, or application. Since the licensee enjoys a kind of monopoly over that use, they’re typically willing to pay higher royalties. This is a strong option when the patent owner wants focused, deep commercialization by one trusted partner.

Non-exclusive licensing allows multiple licensees to use the same technology simultaneously. While individual royalty rates may be lower, the licensor can reach multiple market segments or geographies at once – often resulting in higher aggregate revenue. This works well for technologies with broad applicability.

Field-of-use licensing restricts each licensee to a specific application or industry. A biotech company, for instance, might license the same polymer technology to one company for pharmaceutical packaging and another for industrial use – collecting royalties from both without conflict.

Consider a practical example: an Indian startup develops a novel drug delivery system but doesn’t have the infrastructure to sell it globally. By licensing the technology to established multinational pharmaceutical companies, the startup can earn royalties from global sales while focusing on R&D. This is exactly how transactional strategy allows smaller players to punch above their weight.

Cross-licensing: trading technology to gain technology 🔗

Cross-licensing involves two or more companies granting each other access to their respective patents – a reciprocal exchange of rights. This arrangement is particularly common in industries where a single product may involve dozens of patents, such as semiconductors, telecommunications, and consumer electronics. No single company owns all the pieces it needs, so they trade access instead of fighting over it.

Cross-licensing serves several strategic purposes simultaneously. First, it allows each party to legally use technology they couldn’t otherwise access without incurring high licensing fees. Second, it reduces the risk of costly patent infringement litigation – if both companies have agreed to cross-license, neither has strong incentive to sue the other. Third, it can strengthen industry relationships and lay the groundwork for deeper collaboration.

Explicit vs. silent cross-licenses 🔗

Cross-licensing can be formal or informal. An explicit cross-license is a documented agreement where both parties spell out the terms – which patents are covered, the duration, geographic scope, and whether any balancing payment is required. When one company brings a significantly larger portfolio to the table, the other party may still need to pay a fee to compensate for the imbalance. A silent cross-license, on the other hand, is an informal arrangement where both companies effectively choose not to sue each other because they know their products infringe each other’s patents. It is an unspoken truce – each side knows that initiating litigation would expose it to counter-claims. The well-known dynamic between Google and Microsoft is often cited in this context.

For Indian telecom equipment manufacturers or IT firms looking to work with global technology standards, cross-licensing is often the gateway. Without it, operating in patent-dense sectors like 5G or wireless communication is practically impossible.

Patent pools: licensing simplified for entire industries 🔗

When multiple patent holders contribute their patents to a shared licensing platform, the result is a patent pool. Any company that needs access to those technologies can obtain a single license covering all pooled patents, rather than negotiating separately with each patent holder. Patent pools are especially common in industries that rely on technical standards, such as digital communications, where compatibility across products and manufacturers is critical.

Patent pools benefit all participants. For patent holders, they provide a steady royalty stream and reduce transaction costs. For licensees, they dramatically simplify the process of gaining access to essential technologies. For industries as a whole, pools facilitate the adoption of common standards, which drives interoperability and consumer adoption. Contributors to patent pools typically receive royalties proportional to the value or number of patents they contribute, making portfolio strength a direct driver of earnings.

Generating revenue from royalties: structuring the payment 🔗

Royalty structures are a critical element of any out-licensing or cross-licensing deal. The two primary models are running royalties – a percentage of sales revenue paid periodically as the technology is used – and lump-sum payments, where the licensee pays a one-time fee upfront. Each model has implications for cash flow, risk allocation, and long-term returns.

Running royalties align the licensor’s earnings with the commercial success of the licensed technology, which is ideal when the market potential is uncertain. Lump-sum payments transfer risk to the licensor but provide immediate, predictable revenue. In practice, many licensing agreements use a hybrid of both – an upfront fee combined with ongoing royalties tied to sales volume.

When valuing a patent for licensing purposes, two common approaches are used: the income approach, which estimates the future revenue the technology can generate, and the market approach, which benchmarks the patent against comparable transactions in the industry. Indian companies should be particularly attentive to valuation when entering cross-border licensing deals, where currency, regulatory environment, and market size all affect what a fair royalty rate looks like.

Transactional strategies and market entry 🔗

One underappreciated benefit of licensing as a transactional strategy is its role in enabling market entry. A company that cannot afford to set up manufacturing or distribution in a foreign market can license its technology to a local player there, earning royalties while gaining a foothold. Entering foreign markets becomes significantly easier through licensing, since you avoid the complications of export tariffs, local regulatory compliance, and capital investment – the licensee handles all of that.

For Indian companies with strong R&D capabilities but limited global infrastructure, this is particularly strategic. Instead of building a presence in, say, the European or US market from scratch, an Indian firm can license its technology to an established foreign company and earn steady royalties, while that company handles the market development.

The Indian legal framework: licensing under the Patents Act, 1970 🔗

In India, patent licensing is governed by the Patents Act, 1970, which provides the legal framework for both voluntary and compulsory licensing. Voluntary licensing – where the patent holder willingly grants rights to another party – is the foundation of transactional patent strategy. However, the Act also includes provisions that impose obligations on patent holders, which directly affect licensing strategy.

Under Section 84 of the Patents Act, a compulsory license can be granted after three years from the date of patent grant if the patented invention is not being worked in India, is not available at an affordable price, or does not meet public requirements. This provision is a significant incentive for patent holders to actively license their technology in India rather than simply holding it unused.

The landmark case of Natco Pharma v. Bayer Corporation (2012) illustrates this directly. Bayer held a patent for the cancer drug Sorafenib Tosylate (Nexavar) but was selling it at approximately ₹2,80,000 per month, making it unaffordable for most Indian patients. Natco Pharma applied for a compulsory license under Section 84, and the Indian Patent Office granted it – allowing Natco to sell the drug at ₹8,800 per month, with Bayer receiving a 7% royalty on Natco’s net sales. This case underscores a critical lesson for IP strategy: if a patent holder does not proactively license its technology in India at reasonable terms, the government may effectively do it for them through compulsory licensing.

For businesses building a transactional patent strategy in India, this means that proactive, well-structured voluntary licensing is not just commercially smart – it’s a way to retain control over how your patent is used and at what price.

Mitigating infringement risk through transactional agreements 🔗

One strategic reason companies pursue cross-licensing and patent pool arrangements is to reduce exposure to patent infringement claims. In patent-dense industries, it is virtually impossible for any single company to operate without inadvertently using another company’s patented technology. Rather than risk expensive litigation, companies negotiate licenses proactively.

Settlement licenses – where a company that has been accused of infringement agrees to pay royalties in exchange for the claim being dropped – are another transactional tool. While they can be effective in converting an adversarial situation into a revenue stream, they require careful handling to avoid appearing aggressive or damaging business relationships.

Building a transactional patent strategy: key considerations 🔗

An effective transactional patent strategy starts with a clear portfolio assessment. Not all patents are equally licensable – the most valuable are those covering foundational technologies with broad applications across multiple industries or products. Identifying which patents to actively license, which to keep for defensive use, and which to let lapse is the foundation of any sound IP monetization plan.

From there, companies need to identify the right licensees, structure appropriate payment models, and build monitoring systems to track royalty compliance. Digital licensing platforms and data analytics tools now make it easier to track licensing activity, identify potential infringers, and optimize portfolio management. For Indian startups and SMEs engaging in licensing for the first time, working with a patent attorney or IP licensing firm is strongly advisable to navigate the legal and commercial complexities involved.

What do you think? If a company holds a patent for critical technology but lacks the resources to commercialize it independently, should it prioritize exclusive or non-exclusive licensing – and what factors should drive that decision? And in the Indian context, where compulsory licensing provisions actively pressure patent holders to work their patents locally, how should foreign companies rethink their India-specific patent strategy?

References

1. https://patentpc.com/blog/when-to-use-patent-licensing-for-revenue-and-cost-balance
2. https://thompsonpatentlaw.com/license-and-patent/
3. https://www.lexology.com/library/detail.aspx?g=761701fb-a65e-4717-88fc-b8d0b5f8552f
4. https://blueironip.com/how-patent-licensing-works/
5. https://www.greyb.com/blog/10-patent-licensing-monetization-strategies/
6. https://ttconsultants.com/the-4-step-patent-licensing-strategy/
7. https://indiankanoon.org/doc/799603/
8. https://legalblogs.wolterskluwer.com/patent-blog/compulsory-license-india/
9. https://www.rkdewan.com/blogs/compulsory-licensing-under-indian-patent-act/
10. https://patentpc.com/blog/how-to-maximize-revenue-through-patent-licensing
11. https://patentpc.com/blog/top-patent-licensing-trends-in-the-tech-industry